 | Info Sheets |
| | | | | | | | | | | | | | |
 | Out- side |
| | |
|
| | |
| |
Result : Searchterm 'Microbubbles' found in 1 term [ ] and 58 definitions [ ])
| 1 - 5 (of 59) nextResult Pages : [1] [2 3 4 5 6 7 8 9 10 11 12] | |  | |
 |
Searchterm 'Microbubbles'
was also found in the following service of US-TIP.com: |
|
| | | |  | |  |
 |
US Resources |
|
| | | |  |  |  |
| Albunex |   |
| |
|
Albunex and Infoson, used mainly in cardiac evaluations, are first generation one-pass-only contrast agents and have been replaced by the new-generation contrast media. Albunex and Infoson are the same sonicated human serum albumin microbubbles. Infoson is licensed and manufactured in Europe, while Albunex was produced in the USA.
Albunex, an air-filled microbubble with a denatured albumin shell (modified from air-filled albumin microspheres prepared from sonicated 5% human serum albumin), was the first FDA-approved contrast agent, but is no longer in production.
Cardiac shunts and valve regurgitations are often evaluated with Color Doppler Imaging (CDI), which also improved with injections of Albunex, but this agent is pressure-sensitive and does not recirculate. It is effectively a one-pass-only agent, limiting its clinical efficacy.
See also First generation USCA, Echocardiography and Contrast Enhanced Ultrasound.
|
| Drug Information and Specification: |
| DEVELOPER |
Mallinckrodt Inc.
|
| INDICATION |
Contrast sonography and Doppler-echocardiography |
| APPLICATION |
Intravenous injection |
| TYPE |
Microbubble |
| SHELL - STABILIZATION |
Albumin |
| GAS |
Air |
| DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
|
|
| |  | |
Further Reading: |
News & More:
|
| | |
|  |
 |
Searchterm 'Microbubbles'
was also found in the following service of US-TIP.com: |
|
| | | |
|
 | |  |
 |
US Resources |
|
| | | |  |  |  |
| Backscattering |  |
| |
|
| |  | |
Further Reading: |
Basics:
|
|
News & More:
| | | |
|  |
 |
Searchterm 'Microbubbles'
was also found in the following service of US-TIP.com: |
|
| | | |
|
 |  |
| BG1135 |   |
| |
|
From Bracco Research S. A., Geneva, Switzerland
BG1135 is a polymer-shelled new ultrasound contrast agent under development. The air-filled microsphere has a rigid, 100 nm thick polymeric shell and a mean diameter of 2.9 mm with 99% less than 8 mm.
The destruction mechanism of BG1135 is unique among microbubbles. The microbubbles of BG1135 appear to acquire a small shell defect, allowing the filling gas to stream out and creating a new gas bubble, but leaving the old shell intact. No significant differences between the diameters of the shells can be measured before and after insonation even though the agent is fragmented.
|
| Drug Information and Specification: |
| RESEARCH NAME |
BG1135 |
| DEVELOPER |
Bracco Diagnostics, Inc.
|
| DEVELOPMENT STAGE |
Preclinical |
| APPLICATION |
Intravenous |
| TYPE |
Microbubble |
| SHELL |
Polymer |
| GAS |
Air |
| MICROBUBBLE SIZE |
Mean diameter: 2.9 µm 99% < 8µm |
| DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
|
|
| |  | |
Further Reading: |
Basics:
|
| | |
|  |
|
 |
US Resources |
|
| | | |  |  | | |
|
| |
 | Look Ups |
| |